A Radical Concept on Caveolae and Endothelial Dysfunction in Coronary Microvascular Disease in Diabetes
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The risk of cardiovascular disease is markedly elevated in individuals with diabetes, representing the primary cause of morbidity and mortality in these diabetic patients (1). More specifically, individuals with diabetes display dysfunctions in the regulation of blood flow in coronary arterioles (2,3). Importantly, impairments in the appropriate vasodilatory response of myocardial arterioles to various pharmaceutical and physical stimuli can be present even if there is no discernible atherosclerotic blockage in these blood vessels (4,5). Moreover, increased flow-mediated dilation (FMD) in coronary arterioles is an important regulatory mechanism for controlling arteriolar diameter and blood flow in response to changes in wall shear stress, and this mechanism is also impaired in conditions of glucose dysregulation (6,7). While the underlying etiology for the dysfunctions in the coronary microcirculation in diabetes is certainly multifactorial, the contribution of impairments in the endothelial nitric oxide (NO)–generating system and their association with the excess generation of reactive oxygen species (ROS) appears to be crucial in the development of these vascular abnormalities. For example, the impairment of the induction of vasodilation in coronary arterioles in the db/db mouse, a model of obesity-associated insulin resistance and type 2 diabetes, is related to limitations in NO availability (8,9). It is of great interest that NO availability can be compromised by interactions with superoxide anion, with a …
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with diabetes and ACS, despite the poor prognosis and high prevalence of comorbidities, are less likely to receive appropriate treatment such as revascularization, reperfusion, or adequate DAPT.414,415”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [415]
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390 · cited 1×
“It is of great interest that NO availability can be compromised by interactions with superoxide anion, with a by-product of this reaction being the generation of peroxynitrite (OONO(2)), an ROS that itself is known to mediate deleterious effects on the cardiovascular system in diabetes (10).”
BackgroundStandards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253 · cited 1×
“Finally, the discussion, while being quite informative, could have been improved by providing at least some information on the etiology of free radical production in conditions of type 1 and 2 diabetes that contribute to the generation of OONO(2), including the role of nutrient overload (elevations in both glucose and…”
BackgroundReactive oxygen species in cardiovascular disease
Sugamura, K., & Keaney (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.004 · Cited by 769 · cited 1×
“Finally, the discussion, while being quite informative, could have been improved by providing at least some information on the etiology of free radical production in conditions of type 1 and 2 diabetes that contribute to the generation of OONO(2), including the role of nutrient overload (elevations in both glucose and…”
BackgroundOxidative stress and the etiology of insulin resistance and type 2 diabetes
Henriksen, E. J., Diamond-Stanic, M. K., & Marchionne, E. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.005 · Cited by 600 · cited 1×
“Finally, the discussion, while being quite informative, could have been improved by providing at least some information on the etiology of free radical production in conditions of type 1 and 2 diabetes that contribute to the generation of OONO(2), including the role of nutrient overload (elevations in both glucose and…”
BackgroundSelf-citationInsulin resistance and endothelial dysfunction: the road map to cardiovascular diseases
Cersosimo, E., & DeFronzo, R. A. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.634 · Cited by 525 · cited 1×
“More specifically, individuals with diabetes display dysfunctions in the regulation of blood flow in coronary arterioles (2,3).”
BackgroundVincent, M. A., Barrett, E. J., Lindner, J. R., Clark, M. G., & Rattigan, S. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00021.2003 · Cited by 305 · cited 1×
“(11) is to assess whether these endothelial dysfunctions in feed arterioles also exist in skeletal muscle tissue in human diabetes, especially in type 2 diabetes, as NO-regulated blood flow to this tissue has a major impact on the delivery of glucose, insulin, and other factors to skeletal muscle, and plays an importa…”
BackgroundSkeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species
Wei, Y., Chen, K., Whaley-Connell, A. T., Stump, C. S., Ibdah, J. A., & Sowers, J. R. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00561.2007 · Cited by 258 · cited 1×
“Finally, the discussion, while being quite informative, could have been improved by providing at least some information on the etiology of free radical production in conditions of type 1 and 2 diabetes that contribute to the generation of OONO(2), including the role of nutrient overload (elevations in both glucose and…”
BackgroundJACOB, S., RETT, K., & HENRIKSEN, E. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00141-1 · Cited by 207 · cited 1×
“There is no description of the oral antidiabetic and antihypertensive medications the diabetic subjects were taking, some of which are certainly vasomodulatory compounds that could potentially confound the results (13).”
BackgroundSelf-citationHenry, R. M. A., Ferreira, I., Kostense, P. J., Dekker, J. M., Nijpels, G., Heine, R. J., Kamp, O., Bouter, L. M., & Stehouwer, C. D. A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.002 · Cited by 186 · cited 1×
“Moreover, increased flow-mediated dilation (FMD) in coronary arterioles is an important regulatory mechanism for controlling arteriolar diameter and blood flow in response to changes in wall shear stress, and this mechanism is also impaired in conditions of glucose dysregulation (6,7).”
BackgroundBagi, Z., Koller, A., & Kaley, G. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00718.2003 · Cited by 172
Lambert, J., Aarsen, M., Donker, A. J. M., & Stehouwer, C. D. A. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.5.705 · Cited by 141
Nitenberg, A., Paycha, F., Ledoux, S., Sachs, R., Attali, J.-R., & Valensi, P. (1998) · Circulation · doi:10.1161/01.cir.97.8.736 · Cited by 126 · cited 1×
“Importantly, impairments in the appropriate vasodilatory response of myocardial arterioles to various pharmaceutical and physical stimuli can be present even if there is no discernible atherosclerotic blockage in these blood vessels (4,5).”
BackgroundCassuto, J., Dou, H., Czikora, I., Szabo, A., Patel, V. S., Kamath, V., Belin de Chantemele, E., Feher, A., Romero, M. J., & Bagi, Z. (2014) · Diabetes · doi:10.2337/db13-0577 · Cited by 122 · cited 6×
“(11) provide important new information regarding the underlying cellular mechanisms responsible for vasomotor dysfunctions in coronary arterioles in diabetic humans.”
BackgroundInfluentialNitric oxide directly promotes vascular endothelial insulin transport
Wang, H., Wang, A. X., Aylor, K., & Barrett, E. J. (2013) · Diabetes · doi:10.2337/db13-0627 · Cited by 117
Bagi, Z., Koller, A., & Kaley, G. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00235.2003 · Cited by 115 · cited 1×
“For example, the impairment of the induction of vasodilation in coronary arterioles in the db/db mouse, a model of obesity-associated insulin resistance and type 2 diabetes, is related to limitations in NO availability (8,9).”
BackgroundSubcellular Localization of Oxidants and Redox Modulation of Endothelial Nitric Oxide Synthase
Maron, B. A., & Michel, T. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-1207 · Cited by 76 · cited 3×
“(11), which appears in this issue, the specific impact of OONO(2) on the endothelial caveolae, which is required for the proper functionality of endothelial NO synthase (eNOS) (12), and the subsequent effect of this interaction on NO-regulated FMD in response to changes in wall shear stress in conditions of human diab…”
BackgroundCoronary Artery Spasm and the Polymorphisms of the Endothelial Nitric Oxide Synthase Gene
Kaneda, H., Taguchi, J., Kuwada, Y., Hangaishi, M., Aizawa, T., Yamakado, M., Ogasawara, K., Aizawa, T., & Ohno, M. (2006) · Circulation Journal · doi:10.1253/circj.70.409 · Cited by 57 · cited 1×
“Importantly, impairments in the appropriate vasodilatory response of myocardial arterioles to various pharmaceutical and physical stimuli can be present even if there is no discernible atherosclerotic blockage in these blood vessels (4,5).”
BackgroundBagi, Z. A., Fehér, A., & Beleznai, T. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70011-8 · Cited by 18 · cited 2×
“More specifically, individuals with diabetes display dysfunctions in the regulation of blood flow in coronary arterioles (2,3).”
Background
Cited by
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Wardill, H. R., Mander, K. A., Van Sebille, Y. Z. A., Gibson, R. J., Logan, R. M., Bowen, J. M., & Sonis, S. T. (2016) · International Journal of Cancer · doi:10.1002/ijc.30252 · Cited by 174
Avogaro, A., Bonora, E., Consoli, A., Prato, S. D., Genovese, S., & Giorgino, F. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119845612 · Cited by 62
A Saudi Heart Association Position Statement on Cardiovascular Diseases and Diabetes Mellitus
AlHabeeb, W., Elasfar, A., Kinsara, A. J., Aljizeeri, A. H., Jelaidan, I., Alghalayini, K. W., AlKheraiji., M. F., Akbar, M. A. J., Lawand, S., Alyousif, S. M., et al. (2024) · Journal of the Saudi Heart Association · doi:10.37616/2212-5043.1407 · Cited by 11
“Another observation of note among people with DM is the higher occurrence of multi-vessel disease, multiple coronary lesions and highly vulnerable atherosclerotic plaques associated with impaired microvascular vasodilation [191,192].”
Metadata
- Authors
- Henriksen, E. J.
- Affiliations
- University of Arizona (US)
- Corresponding author
- Henriksen, Erik J.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-03-13
- Volume
- 63
- Issue
- 4
- Pages
- 1200-1202
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2137655765
- Cited by
- 4
- References
- 20
- Citations by year
- 2024: 1 · 2023: 1 · 2019: 1 · 2016: 1
- FWCI
- 0.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Caveolin-1 and cellular processes
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- caveolae, endothelial dysfunction, coronary microvascular dysfunction, nitric oxide, reactive oxygen species, superoxide, flow-mediated dilation, coronary arterioles, db/db mice, insulin resistance, type 2 diabetes
- MeSH terms
- Animals, Diabetes Mellitus, Female, Humans, Male, Vasodilation, Caveolae, Peroxynitrous Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.